1. Home
  2. RFL vs BAFN Comparison

RFL vs BAFN Comparison

Compare RFL & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BAFN
  • Stock Information
  • Founded
  • RFL 2017
  • BAFN 1999
  • Country
  • RFL United States
  • BAFN United States
  • Employees
  • RFL N/A
  • BAFN N/A
  • Industry
  • RFL Real Estate
  • BAFN Savings Institutions
  • Sector
  • RFL Finance
  • BAFN Finance
  • Exchange
  • RFL Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • RFL 54.4M
  • BAFN 63.2M
  • IPO Year
  • RFL N/A
  • BAFN N/A
  • Fundamental
  • Price
  • RFL $1.41
  • BAFN $8.51
  • Analyst Decision
  • RFL
  • BAFN
  • Analyst Count
  • RFL 0
  • BAFN 0
  • Target Price
  • RFL N/A
  • BAFN N/A
  • AVG Volume (30 Days)
  • RFL 122.7K
  • BAFN 19.3K
  • Earning Date
  • RFL 11-05-2025
  • BAFN 10-23-2025
  • Dividend Yield
  • RFL N/A
  • BAFN 3.81%
  • EPS Growth
  • RFL N/A
  • BAFN 100.65
  • EPS
  • RFL N/A
  • BAFN 1.89
  • Revenue
  • RFL $732,000.00
  • BAFN $78,211,000.00
  • Revenue This Year
  • RFL N/A
  • BAFN N/A
  • Revenue Next Year
  • RFL N/A
  • BAFN N/A
  • P/E Ratio
  • RFL N/A
  • BAFN $4.24
  • Revenue Growth
  • RFL 35.56
  • BAFN 0.67
  • 52 Week Low
  • RFL $1.28
  • BAFN $6.40
  • 52 Week High
  • RFL $3.19
  • BAFN $19.75
  • Technical
  • Relative Strength Index (RSI)
  • RFL 44.41
  • BAFN 40.97
  • Support Level
  • RFL $1.31
  • BAFN $7.97
  • Resistance Level
  • RFL $1.48
  • BAFN $8.77
  • Average True Range (ATR)
  • RFL 0.12
  • BAFN 0.34
  • MACD
  • RFL 0.01
  • BAFN 0.13
  • Stochastic Oscillator
  • RFL 40.74
  • BAFN 24.66

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: